| US 7,598,276 B2 | ||
| Pharmaceutical salts and polymorphs of a factor Xa inhibitor | ||
| Craig Grant, Burwell (United Kingdom); James P. Kanter, San Ramon, Calif. (US); and Graeme Langlands, Soham (United Kingdom) | ||
| Assigned to Millenium Pharmaceuticals, Inc., Cambridge, Mass. (US) | ||
| Filed on Nov. 07, 2006, as Appl. No. 11/594,280. | ||
| Claims priority of provisional application 60/735224, filed on Nov. 08, 2005. | ||
| Prior Publication US 2007/0112039 A1, May 17, 2007 | ||
| Int. Cl. A61K 31/44 (2006.01); C07D 213/53 (2006.01) | ||
| U.S. Cl. 514—352 [546/309] | 5 Claims |
1. A salt represented by Formula II:
 |